Increasing Demand for Healthcare Education to Augment the Healthcare Education Solution Market Growth

 

Healthcare Education Solution Market

Healthcare education solution is designed to help individuals and communities. This is very important because it gives information about the social, emotional, mental, and physical health. Healthcare education solution motivates people to improve and maintain their health, prevent disease, and reduce risky behaviors.

There are three types of healthcare education. The first type gives information about the human body structure and its emotional and physical functions. The second gives information about the medical and social services and the third one gives the information regarding the influence of environmental and social factors on individuals and communities.

Market Dynamics:

Increasing launches by key players in the market are expected to propel the growth of the healthcare education solution market. For instance, in February 2021, Elsevier announced the launch of the Simulation Learning System (SLS) for RN with Virtual Reality, a new digital solution that combines cutting-edge virtual reality technology from SimX with the world-class healthcare content of Elsevier to bring realistic and highly effective VR simulations to nursing schools.

Moreover, increasing demand for online learning, increasing adoption of advanced technology, changing technologies in the healthcare industry, and need for healthcare education due to strict regulatory mandates are expected to augment the healthcare education solution market growth.

The emergence of COVID-19 is expected to offer lucrative growth opportunities for players in the healthcare education solution market. The pandemic has led to an increase in remote patient contact counseling or telemedicine. For instance, the usage of telemedicine increased by 63% in the third week of March 2020.

However, the shortage of health workers or health professionals is expected to restrain the growth of the healthcare education solution market. For instance, according to the World Health Organization, the world will be short of 12.9 million health-care workers by 2035.

Asia Pacific is expected to witness robust growth in the market due to strategic partnerships and collaborations between key players and hospitals in the region. For instance, in February 2021, Apollo Hospitals and Anatomiz3D Medtech teamed up to establish hospital 3D printing labs in India to provide medical 3D printing services for better healthcare, through the creation of anatomical models for pre-surgical planning and education, patient-specific cutting and drilling guides, and customized implants and implant molds.

Competitive Analysis:

Major players operating in the healthcare education solution market are Olympus Corporation, Canon Medical, Zimmer Biomet, Medtronic, Stryker, Koninklijke Philips, Johnson & Johnson, GE Healthcare, Siemens Healthineers, Elsevier, and FUJIFILM Holding Corporation.

Major players in the market are adopting various strategies, such as partnership, collaboration, etc., to enhance their market position. For instance, in 2019, GE Healthcare and Ultrasound Podcast collaborated to enhance of point care ultrasound education and training activities.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more